Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1309 clinical trials
An N-of-1 Trial of an Internet-delivered CBT Program Based on the Psychological Flexibility Model of Chronic Pain for Cancer-related Difficulties

</p><p>The investigators will pilot test the modified treatment program in N-of-1 Trials that permit to estimate both between and within subject treatment effects, as well as processes that explain treatment outcome at the individual level, with a high degree of confidence.</p>

  • 0 views
  • 15 Jan, 2025
Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions  

Possible significant differences in cytokine levels will reveal that these proteins and enzymes can be utilized as a diagnostic tool in periodontal diseases, to distinguish periodontal disease status from healthy, or as a guide for treatments.

  • 0 views
  • 08 May, 2025
AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive Metastatic NSCLC

This is an international, randomized, open-label, Phase 3 study designed to evaluate whether the potent and selective RET inhibitor, pralsetinib, improves outcome when compared to a platinum chemotherapy-based regimen chosen by the Investigator from a list of standard of care treatments, as measured primarily by progression free survival (PFS), for …

non-small cell lung cancer
immunomodulators
metastatic non-small cell lung cancer
lung cancer
neoplasms by site
  • 0 views
  • 19 Feb, 2024
The Alberta NutrIMM Study - Nutrition and Immunity

Results of the study will be compared to results of the control group (which will go through the same activities as the experimental groups).

hdl cholesterol
diabetes
glycosylated hemoglobin
fasting
hba1c
  • 0 views
  • 19 Feb, 2024
Multi-CAR-T Cells Targeting B Cell Lymphomas

This study aims to evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells targeting B cell surface molecules including CD19 and alternative CARTs as booster and consolidation treatment for patients with highly resistant B cell lymphomas, including primary mediastinal B cell lymphoma (PMBCL) …

  • 0 views
  • 19 Feb, 2024
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow …

vasectomy
schwannoma
bilateral tubal ligation
ependymoma
investigational drug
  • 0 views
  • 19 Feb, 2024
Enzalutamide Treatment in COVID-19

Enzalutamide is an antiandrogen inhibiting the expression of androgen regulated proteins, such as TMPRSS2. The aim of this trial is to evaluate a possible beneficial effect of short-term enzalutamide treatment of COVID-19 patients.

enzalutamide
oral contraceptives
covid-19
  • 0 views
  • 19 Feb, 2024
Intervention for Fluency Difficulty

The focus of the study is to identify children with word-finding difficulty and other speech and communication difficulties such as stuttering, a procedure referred to as screening. Ideally, investigators want to screen all children in the reception classes in the schools with which investigators work.

stuttering
  • 0 views
  • 19 Feb, 2024
Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars

Non-suicidal self-inflicted (NSSI) scars can act as a physical reminder of previous self-inflicted self-harm, thereby not only worsening the symptoms of depression and self-doubt but also leading to recurrent self-infliction and social exclusion.

dermabrasion
scar
laser therapy
supportive psychotherapy
  • 0 views
  • 19 Feb, 2024
Respiratory Muscle Training (RMT) in ALS

Participants will be stratified into 2 groups based on baseline inspiratory muscle strength as determined by maximum inspiratory pressure (MIP): six participants with minimal to no respiratory weakness (i.e., MIP 70% predicted) and six participants with mild to moderate inspiratory weakness (i.e., MIP 40-70% predicted).

weakness
respiratory muscle training
maximum inspiratory pressure
maximum expiratory pressure
  • 0 views
  • 19 Feb, 2024